Mene Pangalos is the man tasked with nothing less than firing up the discovery engine of Britain’s second-biggest drug maker after its catastrophic fall off the “patent cliff”.
He joined AstraZeneca as head of innovative medicines in 2010, as the company was bracing for patents to expire on a string of its best-selling drugs.
{iframe}http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10775160/AstraZeneca-reinforces-pipeline-with-open-innovation.html{/iframe}